Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Puma Biotechnology
Puma Biotechnology
Why These 3 Biotech Stocks Could Outperform Their Peers In 2018
Investors Business Daily
Sat, 01/6/18 - 12:32 pm
biotech
Puma Biotechnology
Incyte
Clovis Oncology
Negligible Benefit Of Nerlynx, A New Breast Cancer Drug, Calls For Caution In Prescribing
Forbes
Fri, 11/17/17 - 11:10 am
Nerlynx
breast cancer
Puma Biotechnology
Former Puma Biotech executive pleads guilty to insider trading
Reuters
Fri, 11/3/17 - 09:11 am
Puma Biotechnology
insider trading
3 Drug Stocks Poised to Surpass Estimates in Q2 Earnings
Yahoo/Zacks.com
Wed, 08/9/17 - 09:41 am
earnings
Puma Biotechnology
Alnylam
Impax Labs
Does Puma's quick Nerlynx launch play into its buyout prospects?
Fierce Pharma
Tue, 08/1/17 - 11:30 am
Puma Biotechnology
Nerlynx
breast cancer
M&A
FDA's Flashing Green Light Boosts Novel Drug Approvals
Seeking Alpha
Thu, 07/20/17 - 06:03 pm
FDA
drug approvals
Gilead Sciences
Puma Biotechnology
Vosevi
Nerlynx
Does Puma Biotechnology's Approval Make It Worth More?
Motley Fool
Wed, 07/19/17 - 10:00 am
Puma Biotechnology
Nerlynx
breast cancer
Puma granted broad label for neratinib after FDA OK
BioPharma Dive
Wed, 07/19/17 - 09:31 am
Puma Biotechnology
neratinib
breast cancer
Nerlynx
Puma wins big FDA OK for neratinib after running the gamut with investors
Endpoints
Mon, 07/17/17 - 06:50 pm
Puma Biotechnology
neratinib
breast cancer
Nerlynx
Puma's FDA Decider And Semaglutide's Head-To-Head Battle
Seeking Alpha
Mon, 07/10/17 - 11:09 am
Puma Biotechnology
FDA
Novo Nordisk
Nerlynx
neratinib
semaglutide
5 Biotech Stocks With Major Catalysts in July
Motley Fool
Wed, 06/28/17 - 11:03 pm
biotech
AcelRx
Zalviso
Alnylam
Patisiran
Dynavax
HEPLISAV-B
GSK
Benlysta
Puma Biotechnology
neratinib
Pfizer Fueling Growth Of Competitors' Pipelines
Forbes
Tue, 06/27/17 - 10:02 am
Pfizer
R&D
Clovis Oncology
Puma Biotechnology
Bioventus
Shire
AstraZeneca
5 Best Biotech Stocks of 2017 So Far
Motley Fool
Mon, 06/26/17 - 09:41 am
biotech
Alnylam
Puma Biotechnology
Immunogen
Sangamo BioSciences
Calitera
Prescribed Reading: FDA on a roll, while pharma continues sell off
BioPharma Dive
Tue, 05/30/17 - 10:07 am
FDA
Roche
Ocrevus
Puma Biotechnology
neratinib
Novartis
FDA Panel Votes 12 To 4 to Approve Puma's Breast Cancer Drug
Forbes
Thu, 05/25/17 - 08:51 am
FDA
Puma Biotechnology
breast cancer
advisory panels
neratinib
Puma Biotechnology FDA Live Blog
Forbes
Wed, 05/24/17 - 10:39 am
FDA
Puma Biotechnology
advisory panels
neratinib
breast cancer
Puma shares jump 40% after FDA review but brief leaves scope for AdComm grilling and neratinib rejection
Fierce Biotech
Tue, 05/23/17 - 08:13 am
Puma Biotechnology
neratinib
breast cancer
FDA review raises some serious questions for Puma, but shares rocket up on positive notes
Endpoints
Mon, 05/22/17 - 10:21 am
FDA
Puma Biotechnology
neratinib
breast cancer
advisory panels
Shortened FDA Advisory Panel Is Bad Omen for Puma Bio's Controversial Breast Cancer Drug
TheStreet.com
Tue, 04/18/17 - 09:13 pm
FDA
advisory panels
Puma Biotechnology
neratinib
breast cancer
Top Biotech Stocks With FDA Decisions in 2017
Motley Fool
Fri, 03/3/17 - 09:42 am
FDA
Flexion
Zilretta
knee pain
osteoarthritis
neratinib
Puma Biotechnology
breast cancer
Portola
betrixaban
bloodthinners
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »